Can imipramine cause nightmares

Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev. Thase ME. Depression, sleep, and antidepressants. J Clin Psychiatr. Sleep and sleep electroencephalogram in depressed patients treated with phenelzine. Arch Gen Psychiatr. Posttraumatic stress disorder in Israeli combat veterans. Total prolonged drug-induced REM sleep suppression in anxious-depressed patients.

Palladino A. Adverse reactions to abrupt discontinuation of phenelzine. J Clin Psychopharmacol. Mono-amine oxidase inhibitors, sleep and mood.

Electroencephalogr Clin Neurophysiol. Drugs and dreams. II imipramine and prochlorperazine. Compr Psychiatr. Drugs of dependence though not of abuse: fenfluramine and imipramine. Br Med J. Drugs and dreams 3. Am J Psychiatr. Dream recall and major depression: a preliminary report.

Antidepressant withdrawal symptoms treated with anticholinergic agents. Dream activation by thymoleptics. Dreaming without REM sleep. Conscious Cogn. Hoque R, Chesson AL. J Clin Sleep Med. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in sleep.

Hartmann E, Cravens J. Long-term psychotropic drug administration: effects on dream content and dream density. Sleep Res. Recurrence of depression after discontinuation of long-term amitriptyline treatment. Investigations of morning and laboratory dream recall and content in depressive patients during baseline conditions and under antidepressive treatment with trimipramine.

Psychiatr J Univ Ott. The effect of trimipramine on dream recall and dream emotions in depressive outpatients. Psychiatr Res. Flemenbaum A. Pavor nocturnus: a complication of single daily tricyclic or neuroleptic dosage. Frightening dreams and dosage schedule of tricyclic and neuroleptic drugs. J Nerv Ment Dis. Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients. Nightmares related to fluoxetine treatment. Clin Neuropharmacol.

Markowitz JC. Fluoxetine and dreaming. The fluoxetine-mediated increase in NREM eye movements can be detected in the home setting using the Nightcap. Balon R. Sexual obsessions associated with fluoxetine. An angry bed partner. SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects.

Parish JM. Violent dreaming and antidepressant drugs: or how paroxetine made me dream that I was fighting Saddam Hussein.

Davidson JR. Treatment of posttraumatic stress disorder: the impact of paroxetine. Psychopharmacol Bull.

Changes in dream experience in relation with antidepressant escitalopram treatment in depressed female patients: a preliminary study. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study. Acta Psychiatr Scand. Int Clin Psychopharmacol. Zullino DF, Riquier F. Venlafaxine and vivid dreaming. Schuttle S. REM behavior disorder seen with venlafaxine effexor.

Effects of duloxetine in treatment-refractory men with posttraumatic stress disorder. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.

Diabetes Care. Lemoine P, Faivre T. Subjective and polysomnographic effects of milnacipran on sleep in depressed patients. Hum Psychopharmacol. Lewis JD. Mirtazapine for PTSD nightmares. Am J Psychiatry. Mirtazapine induced nightmares in an adult male.

Br J Clin Pharmacol. Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients. The antidepressant drug; trazodone inhibits Tau amyloidogenesis: prospects for prophylaxis and treatment of AD. Arch Biochem Biophys. Menza MA. Withdrawal syndrome in a depressed patient treated with trazodone. Trazodone ameliorates nightmares in major depressive disorder.

J Neuropsychiatry Clin Neurosci. Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares. An observational study of insomnia and nightmare treated with trazodone in patients with advanced cancer. Am J Hosp Palliat Care. The serotonergic antidepressant nefazodone inhibits the serotonin transporter : in vivo and ex vivo studies. Life Sci. Wilson S, Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects.

The effect of nefazodone on subjective and objective sleep quality in posttraumatic stress disorder. Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response. Int J Neuropsychopharmacol.

REM sleep enhancement by bupropion in depressed men. REM sleep behavior disorder in psychiatric populations. Perceptual changes with bupropion, a novel antidepressant. The disposition of bupropion and its metabolites in healthy male volunteers after single and multiple doses. Eur J Clin Pharmacol.

Bupropion and nightmares. The neurobiological properties of tianeptine Stablon : from monoamine hypothesis to glutamatergic modulation. Mol Psychiatr. Tianeptine in an experimental medicine model of antidepressant action. J Psychopharmacol. Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline.

State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine. Agomelatine in depressive disorders: its novel mechanisms of action. J Neuropsychiatr Clin Neurosci. The preclinical discovery and development of agomelatine for the treatment of depression.

Expert Opin Drug Discov. Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients. Phase-shifts of h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin Endocrinol. Agomelatine for the treatment of posttraumatic stress disorder: a case report.

Ann Clin Psychiatr. Prescription drugs used in Insomnia. Monti JM, Monti D. Sleep in schizophrenic patients and the effects of antipsychotic drugs. Exp Med Surg. Gaillard JM, Moneme A. Modification of dream content after preferential blockade of mesolimbic and mesocortical dopaminergic systems. J Psychiatr Res. Dream content in male schizophrenic patients. To provide you with the most relevant and helpful information and to understand which information is beneficial, we may combine your e-mail and website usage information with other information we have about you.

If we combine this information with your PHI, we will treat all of that information as PHI, and will only use or disclose that information as set forth in our notice of privacy practices.

You may opt-out of e-mail communications at any time by clicking on the Unsubscribe link in the e-mail. Our Housecall e-newsletter will keep you up-to-date on the latest health information. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes. Mayo Clinic does not endorse companies or products.

Advertising revenue supports our not-for-profit mission. Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below. This site complies with the HONcode standard for trustworthy health information: verify here. This content does not have an English version. Select personalised ads. Apply market research to generate audience insights.

Measure content performance. Develop and improve products. List of Partners vendors. If you have clinical depression, you're probably familiar with the wee hours of the morning. Depression is known to cause sleep disturbances such as insomnia, early morning awakenings, and bad dreams or nightmares. Specifically, depression decreases the length of time it takes to enter REM sleep called REM sleep latency and increases the frequency of rapid eye movements during sleep called REM sleep density.

Ironically, antidepressants, which treat depression, can also impact your dreams through affecting REM sleep. Research has shown that antidepressants may induce positive or negative dream emotions, influence how often you dream, and decrease your recall of dreams. In a report that was published in Sleep Medicine Reviews , Gotthard Tribl and his research team completed a systematic review that examined the impact of antidepressants on dream content in both depressed and non-depressed individuals.

Out of all the studies that had been published over a period of 60 years, they found a total of 21 clinical studies and 25 case reports that were eligible for review. The studies compared dream content across a spectrum of different antidepressants as well as making comparisons between the dream content of those taking or not taking an antidepressant.

What the study authors found was that taking antidepressants tends to make both depressed and non-depressed individuals remember their dreams less often. Tricyclics are older antidepressants that inhibit the reuptake of serotonin and norepinephrine. They include such medications as Elavil amitriptyline , Anafranil clomipramine , Tofranil imipramine , and Surmontil trimipramine. Antidepressants belonging to the SSRI class, as well as serotonin-norepinephrine reuptake inhibitors SNRIs , were found in the review to intensify dreams and increase how often people reported having nightmares.

Tricyclics, on the other hand, tended to produce more positive dreams while withdrawal of antidepressants usually caused an increase in dream recall and more frequent nightmares.